Key result
Clerodendrum chinensis extracts produce dose-dependent reductions in mean arterial pressure in hypertensive rats.
Why the study?
The rise in hypertension, a major factor for chronic renal failure, cardiovascular disease, stroke, and sudden death, is of concern.
Do Clerodendrum Chinensis Extracts (AeC and EeC) reduce blood pressure in L-NAME hypertensive experimental models?
Do Clerodendrum Chinensis Extracts (AeC and EeC) reduce blood pressure in L-NAME hypertensive experimental models?
p-value: p=<0.05
Clerodendrum Chinensis extracts (AeC and EeC) show potential as rapid antihypertensive agents in preclinical L-NAME models.
May indicate rapid antihypertensive activity in rat models; hypothesis-generating and should not yet change practice.
Background: The rise in the occurrence of hypertension, a non-communicable disease and a major factor for chronic renal failure, cardiovascular disease, and stroke, which most times lead to sudden death is worrisome. Resistant hypertension is more common and may have no symptoms at all for months or years, but then can cause heart attack, stroke, and vision and kidney damage. Prevention and quick management of hypertension is therefore essential in reducing the risk of these debilitating ailments. Aqueous and ethanolic extracts of the leaves of Clerodendrum chinensis (AeC and EeC) are used by local communities of West Africa as medicine for rapid anti-hypertensive actions. We aim to discover the scientific basis for the use of the herb as medicine. Methods: This work investigates the anti-hypertensive effects of AeC and EeC in L-Arginine Methyl Ester Hydrochloride (L-NAME)- induced hypertensive rats Acetylcholine, L-Arginine and Sodium Nitroprusside were used as standards. All results were expressed as means ± standard error of mean. Differences were considered significant at p<0.05. Results: Intravenous administration of the extracts caused a significant decrease in the Mean Arterial Blood Pressure (MABP) in a dose-dependent manner. AeC at 100 mg/kg caused a significant decline in blood pressure in a dose-related manner. Likewise, at 100 mg/kg, EeC reduced MABP steadily from 103.9 ± 2.55 to 34.1 ± 0.95mmHg. The two extracts; possess significant anti-hypertensive properties. Conclusions: Both extracts show significant anti-hypertensive effects and at high doses could lead to hypotension and so should be used with care. Further research is necessary to determine safe dosage forms.
No takes yet. Share an insight, caveat, or question.
Odimegwu et al. (2021) studied L-NAME-induced hypertension (n=50). Clerodendrum chinensis aqueous (AeC) and ethanolic (EeC) extracts vs. L-NAME only was evaluated on Mean Arterial Blood Pressure (MABP) (p=<0.05). Intravenous administration of aqueous and ethanolic extracts of Clerodendrum chinensis caused a significant, dose-dependent decrease in mean arterial blood pressure in L-NAME-induced hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: